Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Sept 2026 for BRIAPRO THERAPEUTICS CORP.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jane Gross: trading record in brief
Filings by Jane Gross span 2 companies, the busiest being Briapro Therapeutics Corp. and BriaCell Therapeutics Corp. We count 4 filings; the first trade dates from 31 August 2023 and the latest from 7 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 23 September 2026: a share grant, in Briapro Therapeutics Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jane Gross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
359,000 sharesRestricted Stock UnitsTSXSEDI:4780828
Restricted Stock UnitsTSXSEDI:4780822
15,000 sharesRestricted Share UnitsTSXSEDI:4748039
359,000 sharesCommon SharesTSXSEDI:4701078
4 of 4 declarations
